Dynamic relationship between the aryl hydrocarbon receptor and long noncoding RNA balances cellular and toxicological responses.


Journal

Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032

Informations de publication

Date de publication:
10 2023
Historique:
received: 07 06 2023
revised: 10 08 2023
accepted: 11 08 2023
medline: 23 10 2023
pubmed: 20 8 2023
entrez: 19 8 2023
Statut: ppublish

Résumé

The aryl hydrocarbon receptor (AhR) is a cytosolic transcription factor activated by endogenous ligands and xenobiotic chemicals. Once the AhR is activated, it translocates to the nucleus, dimerizes with the AhR nuclear translator (ARNT) and binds to xenobiotic response elements (XRE) to promote gene transcription, notably the cytochrome P450 CYP1A1. The AhR not only mediates the toxic effects of environmental chemicals, but also has numerous putative physiological functions. This dichotomy in AhR biology may be related to reciprocal regulation of long non-coding RNA (lncRNA). lncRNA are defined as transcripts more than 200 nucleotides in length that do not encode a protein but are implicated in many physiological processes such as cell differentiation, cell proliferation, and apoptosis. lncRNA are also linked to disease pathogenesis, particularly the development of cancer. Recent studies have revealed that AhR activation by environmental chemicals affects the expression and function of lncRNA. In this article, we provide an overview of AhR signaling pathways activated by diverse ligands and highlight key differences in the putative biological versus toxicological response of AhR activation. We also detail the functions of lncRNA and provide current data on their regulation by the AhR. Finally, we outline how overlap in function between AhR and lncRNA may be one way in which AhR can be both a regulator of endogenous functions but also a mediator of toxicological responses to environmental chemicals. Overall, more research is still needed to fully understand the dynamic interplay between the AhR and lncRNA.

Identifiants

pubmed: 37597813
pii: S0006-2952(23)00336-2
doi: 10.1016/j.bcp.2023.115745
pii:
doi:

Substances chimiques

Receptors, Aryl Hydrocarbon 0
RNA, Long Noncoding 0
Xenobiotics 0
Polychlorinated Dibenzodioxins 0
Cytochrome P-450 CYP1A1 EC 1.14.14.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115745

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aeshah Alluli (A)

Meakins-Christie Laboratories, McGill University, Canada; Translational Research in Respiratory Diseases Program at the Research Institute of the McGill University Health Centre, Canada; Department of Pathology, McGill University, Canada.

Willem Rijnbout St James (W)

Meakins-Christie Laboratories, McGill University, Canada; Translational Research in Respiratory Diseases Program at the Research Institute of the McGill University Health Centre, Canada; Department of Pathology, McGill University, Canada.

David H Eidelman (DH)

Meakins-Christie Laboratories, McGill University, Canada; Department of Medicine, McGill University, Canada.

Carolyn J Baglole (CJ)

Meakins-Christie Laboratories, McGill University, Canada; Translational Research in Respiratory Diseases Program at the Research Institute of the McGill University Health Centre, Canada; Department of Pathology, McGill University, Canada; Department of Medicine, McGill University, Canada; Department of Pharmacology and Therapeutics, McGill University, Canada. Electronic address: Carolyn.baglole@mcgill.ca.

Articles similaires

Humans Pulmonary Disease, Chronic Obstructive RNA, Long Noncoding Male Female
Humans Small Cell Lung Carcinoma RNA, Long Noncoding Sulfonamides Animals
Humans Female Ovarian Neoplasms Cell Proliferation RNA, Long Noncoding
Humans Temozolomide RNA, Long Noncoding Glioblastoma Drug Resistance, Neoplasm

Classifications MeSH